Amgen (AMGN, $58.74, up $0.71) continued its winning streak on Monday as the stock made it eight-in-a-row. Shares are benefiting from takeover speculation and that has fueled Amgen’s recent run towards $60. The March 60 calls (YAACL, $2.20, up $0.35) were recommended on February 3 at $1.20 and are nowRead more

More